Home › Funds › G&S Capital LLC › DGX
G&S Capital LLC position in DGX
QUEST DIAGNOSTICS INC · Health Care
G&S Capital LLC reported holding 15,108 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.93% of its reported portfolio and ranking #38 among its reported holdings. G&S Capital LLC has disclosed DGX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How G&S Capital LLC's DGX position evolved
G&S Capital LLC first disclosed a stake in DGX in Q2 2025 at 7,024 shares (US$1.3M). The position peaked in Q2 2026 at 15,108 shares, worth US$3.2M. Across 5 filings, G&S Capital LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 15,108 shares valued at US$3.2M — a reduction of -184 shares quarter over quarter.. Notable position changes include a 117% increase in Q3 2025 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 7.02K | $1.26M | New |
| Q3 2025 | 15.25K | $2.91M | Add |
| Q4 2025 | 15.11K | $2.62M | Reduce |
| Q1 2026 | 15.29K | $3.00M | Add |
| Q2 2026 | 15.11K | $3.20M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on G&S Capital LLC
FAQ
How long has G&S Capital LLC held DGX?
G&S Capital LLC has disclosed DGX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is G&S Capital LLC's current position in DGX?
As of Q2 2026, G&S Capital LLC holds 15.11K shares of DGX (QUEST DIAGNOSTICS INC), valued at $3.20M, representing 0.93% of its reported portfolio and ranking #38.
Has G&S Capital LLC been buying or selling DGX?
In the latest 13F filing (Q2 2026), G&S Capital LLC reduced its position in DGX. The position peaked in Q2 2026 at 15.11K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.